FdaApplication
NDA 213464
Identifiers
- fda_app_no: NDA213464
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2020-08-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMPIT | NIFURTIMOX | 30MG | TABLET;ORAL |
| LAMPIT | NIFURTIMOX | 120MG | TABLET;ORAL |
2 products